Regulatory & Legal

Olenox Industries adds former Under Secretary of State Paula Dobriansky to its board, a move signaling a strategic push into complex global markets.

As Canada launches a bold defence strategy, drone-maker Draganfly recruits a former top general to navigate the multi-billion dollar opportunity.

New data reveals a targeted therapy can help patients with a rare, aggressive lung cancer even after their disease shows signs of worsening.

ABLi Therapeutics reports its drug risvodetinib is the first to lower toxic alpha-synuclein levels in a Phase 2 trial, heralding a new era for patients.

enGene hits the road for key investor conferences, showcasing a promising non-viral gene therapy for a tough-to-treat bladder cancer. Will it succeed?

New research reveals how clinical trial design inflates the placebo effect, offering a key to solving the 90% failure rate for anxiety and depression drugs.

Latest drill results confirm major expansion at Tesla Zone, as Foran Mining pushes toward a multi-deposit critical minerals camp in Saskatchewan.

The REIT is offering a high 9.75% yield for new notes, but investors who refuse the swap could see their current protections vanish. A critical choice looms.

Sai Life Sciences' plan to hire 700+ professionals underscores a global shift, positioning India as a critical hub for pharmaceutical R&D and manufacturing.

Northern Oil and Gas is reducing its share in a $1.2B Ohio Utica asset buy, freeing up capital for future growth while partner INR doubles down.

Travere Therapeutics reports a profitable Q4 driven by its kidney drug FILSPARI, but a revenue miss and a critical FDA decision create a complex outlook.

Warrior Met Coal touts major ESG progress in its new report, but a simultaneous billion-dollar mine expansion in Alabama raises complex questions.

Eight attorneys from the record-setting Dallas firm Hamilton Wingo have been named to the prestigious 2026 Lawdragon 500, affirming their national dominance.

A landmark bill to shield living organ donors from job and insurance discrimination is advancing in the Senate, offering new hope for 90,000+ on the waiting list.

With a securitization 5x oversubscribed, Kiavi unlocks $1.2B in new funding, proving investor confidence in its AI-powered real estate lending platform.

After a tumultuous period, the NACLB conference returns under new leadership, promising stability and a bold agenda focused on AI and economic shifts.

Facing delisting, the Singaporean tech firm enacts a 1-for-20 reverse split. Is it a lifeline or a sign of deeper financial troubles ahead?

Formula 1 is coming to the biggest screen. IMAX and Apple TV are bringing five iconic 2026 Grands Prix live to theaters, redefining the fan experience.

As a gruesome screwworm parasite nears the Texas border, the FDA rushes to authorize treatments for dogs and cats, a critical step in national preparedness.

As Milwaukee faces a housing crisis, a $38M project will preserve 150 affordable homes, adding green upgrades without displacing a single resident.